# AbbVie: Dawn score and attention ranking

AbbVie scores 52 out of 100 on the Dawn Index, built from 4 signals. It ranks #2 of 7 in Biotechnology (S&P 500), #1 of 1 in Biotechnology (Fortune 100), #15 of 57 in Health Care (S&P 500), #4 of 16 in Health Care (Fortune 100).

## What drives the AbbVie Dawn score?

| Signal | Weight | Score (0 to 100) |
| --- | --- | --- |
| Search scale | 20% | 57 |
| Search momentum | 20% | 45 |
| Site scale | 15% | 53 |
| Site momentum | 10% | 60 |

## How does AbbVie compare in Biotechnology (S&P 500)?

| Rank | Brand | Dawn score |
| --- | --- | --- |
| 1 | [Moderna](https://dawntrend.com/brand/moderna) | 66 |
| 2 | [AbbVie](https://dawntrend.com/brand/abbvie) | 52 |
| 3 | [Gilead Sciences](https://dawntrend.com/brand/gilead-sciences) | 50 |
| 4 | [Vertex Pharmaceuticals](https://dawntrend.com/brand/vertex-pharmaceuticals) | 46 |
| 5 | [Incyte](https://dawntrend.com/brand/incyte) | 46 |
| 6 | [Amgen](https://dawntrend.com/brand/amgen) | 41 |
| 7 | [Regeneron Pharmaceuticals](https://dawntrend.com/brand/regeneron-pharmaceuticals) | 38 |

## Where do the numbers come from?

Search figures are Google search estimates for the brand and its products. Site figures are third-party traffic estimates. A Dawn score measures attention, not revenue.

See the full Dawn Index.